Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions

Pancreatic cancer (PDAC) is an aggressive and chemoresistant disease, representing the fourth cause of cancer related deaths in western countries. Majority of patients have unresectable, locally advanced or metastatic disease at time of diagnosis and the 5-year survival rate in these conditions is e...

Full description

Saved in:
Bibliographic Details
Published in:World J Gastroenterol
Main Authors: Giordano, Guido, Pancione, Massimo, Olivieri, Nunzio, Parcesepe, Pietro, Velocci, Marianna, Di Raimo, Tania, Coppola, Luigi, Toffoli, Giuseppe, D’Andrea, Mario Rosario
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Inc 2017
Subjects:
Minireviews
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5583572/
https://ncbi.nlm.nih.gov/pubmed/28932079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v23.i32.5875
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items